|
⚲
|
| Keyboard |
| Juggernaut Partners III GP Ltd | |
|---|---|
| Firm | |
| Address | 4445 Willard Avenue Suite 1040 Chevy Chase, MD 20815 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Juggernaut Foundation CoInvestment LP | 021-298168 | Executive Officer | 42.0 M of 42.0 M |
||
| Juggernaut Management LLC | |||||
| Juggernaut Capital Partners III LP | 021-233165 | Executive Officer | 309.2 M of 350.0 M |
349.6 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Petros Pharmaceuticals Inc PTPI
Common Stock, par value $0.0001 per share
|
2021-12-22 | Buy | 145,773 | $3.43 | 500,001 |
|
Petros Pharmaceuticals Inc PTPI
Warrant · derivative
|
2021-12-22 | Buy | 109,329 | $0.00 | |
|
Petros Pharmaceuticals Inc PTPI
Common Stock, par value $0.0001 per share
|
2021-11-29 | Buy | 500,000 | $3.00 | 1,500,000 |
|
Petros Pharmaceuticals Inc PTPI
Warrant · derivative
|
2021-11-29 | Buy | 375,000 | $0.00 | |
|
Petros Pharmaceuticals Inc PTPI
Common Stock, par value $0.0001 per share
|
2021-10-18 | Buy | 1,661,807 | $1.72 | 2,858,308 |
|
Petros Pharmaceuticals Inc PTPI
Warrant · derivative
|
2021-10-18 | Buy | 1,661,807 | $0.00 |